Meeting
2018 Cancer Survivorship Symposium
Identifying vulnerable populations among breast cancer survivors.
Authors
Kit Yu Lu
UPMC Pinnacle, Harrisburg, PA
Kit Yu Lu , Theresa M. Lee , Megan Lanigan , Yijin Wert , Lisa Torp , Beth Rudge
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Chronic Anticancer Therapy; Late- and Long-term Effects/Comorbitidities; Psychosocial Issues; Risk Assessment
Track
Care Coordination, Cost, and Education,Late- and Long-term Effects/Comorbidities,Health Promotion,Psychosocial Issues,Communication and Transitions,Risk Assessment,Chronic Anti-Cancer Therapy
Sub Track
Quality-of-Life Issues
Citation
J Clin Oncol 36, 2018 (suppl 7S; abstr 176)
DOI
10.1200/JCO.2018.36.7_suppl.176
Abstract #
176
Poster Bd #
D14
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Breakthrough
Exploring depression risk among breast cancer survivors: A nationwide cohort study in South Korea.
First Author: Hea Lim Choi
Poster
2023 ASCO Quality Care Symposium
Elucidating when to engage patients with breast cancer in a symptom-based survivorship intervention.
First Author: Nicholas Peter Verdini
Poster
2022 ASCO Quality Care Symposium
Advice from one patient to another: A qualitative analysis of patients’ perspectives about chemotherapy initiation.
First Author: Catalina Malinowski
Poster
2019 ASCO Annual Meeting
Differential impact of endocrine therapy (ET) and chemotherapy (CT) on quality of life (QoL) of 4,262 breast cancer (BC) survivors: A prospective patient-reported outcomes (PRO) analysis.
First Author: Arlindo R. Ferreira